Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Europe Pharmacovigilance Market Forecast Report with Growth Prospects and Market Sizing 2028The Europe pharmacovigilance market is expected to undergo significant growth during the forecast period owing to the presence of strict regulatory framework for drug testing and approval in the region.
By: Techsci Research Growing incidences and prevalence of chronic diseases such as diabetes, hypertension, cardiovascular diseases, asthma, cancer, among others are likely to strengthen the growth of the market. According to the World Health Organisation (WHO), there are around 60 million people with diabetes in the Europe, out of which 10.3% are men and 9.6% are women aged 25 years and over. Moreover, rising elderly population is also a supporting factor as they are highly susceptible to these diseases. The rising number of cases of chronic diseases in the region is surging the demand for drugs, thereby, fuelling the growth of the market. In 2021, over one fifth (20.8 %) of the Europe population was aged 65 and above. Major players operating in the Europe pharmacovigilance market include Accenture PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb SARL, Clinquest Group B.V., F Hoffmann-La Roche AG, Foresight Group International AG, ICON PLC, GlaxoSmithKline PLC, Novartis AG and Capgemini SE. The companies are investing on R&D activities to offer more advanced services. Some leading players are also undertaking growth strategies such as collaborations, partnerships and alliance to increase their market reach in the region. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Europe Pharmacovigilance Market" https://www.techsciresearch.com/ Download Sample Report @ https://www.techsciresearch.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|